vTv Therapeutics (VTVT) executive compensation, 2026 proxy

Paul Sekhri, President and Chief Executive Officer, was paid $6.6M in 2025, up 72% from $3.9M the year before.

Filed
April 28, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
3
CEO total pay
$6.6M+72% vs prior year
CEO 2025 Total Pay
$6,638,252Increase from prior year
CEO Salary
$673,000Base salary for 2025
CFO Salary
$279,546Michael Tung partial year
Net Loss
$(26,974)KFor fiscal year 2025

How Sekhri was paid

$6.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Option awards84%Non-equity incentive5%All other compensation0%

Named executive officers

ExecutiveTotal
Paul SekhriPresident and Chief Executive Officer$6,638,252
Michael TungExecutive Vice President and Chief Financial Officer$2,441,869
Steven TuchFormer Executive Vice President and Chief Financial Officer$142,298

What changed and why

  • $6.6MCEO total compensation increased to $6,638,252 in 2025 from $3,863,827 in 2024.
  • Option awards formed the majority of the CEO total compensation package in 2025.
  • Michael Tung was appointed executive vice president and chief financial officer effective May 19, 2025.
  • Steven Tuch resigned as executive vice president and chief financial officer effective March 21, 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.